Intravaginal metronidazole/miconazole for the treatment of vaginal trichomoniasis

Sexually Transmitted Diseases

Volumn 40, Issue 9, 2013, Pages 710-714

  Schwebke, Jane R ^a   Lensing, Shelly Y ^b   Sobel, Jack ^c  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ARKANSAS MEDICAL CENTER   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; METRONIDAZOLE; METRONIDAZOLE PLUS MICONAZOLE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG TREATMENT FAILURE; DYSGEUSIA; FEMALE; FOLLOW UP; HUMAN; PH; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; SINGLE DRUG DOSE; SUICIDAL IDEATION; TREATMENT DURATION; TRICHOMONIASIS; VAGINA SMEAR; VAGINAL PRURITUS;

ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; ADULT; ALABAMA; ANTI-INFECTIVE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; METRONIDAZOLE; MICONAZOLE; PILOT PROJECTS; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; SEXUALLY TRANSMITTED DISEASES; SPECIES SPECIFICITY; TREATMENT OUTCOME; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS; YOUNG ADULT;

EID: 84883285423     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/01.olq.0000431069.38601.d5     Document Type: Article

References (23)

1. WHO Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections. Geneva: WHO; 2001.
2. Cates W, Bolan G, Caine V, et al. Incidence and prevalence of STD in the United States. Sex Transm DIs 1998; 26:S2-S7.
3. Cotch MF, Pastorek JG, Nugent RP, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex Transm Dis 1997; 24:361-362.
4. McClelland R, Sangare L, HassanW, et al. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis 2007; 195:698-702.
5. Wølner-Hanssen P, Krieger JN, Stevens CE, et al. Clinical manifestations of vaginal trichomoniasis. JAMA 1989; 261:571-576.
6. Krieger J. Clinical manifestations of trichomoniasis in men. Ann Intern Med 1993; 118:844.
7. CDC. Sexually transmitted diseases treatment guidelines, 2010. MMWR 2010; 59:58-61.
8. Ozyurt E, Toykuliyeva MB, Danilyans IL, et al. Efficacy of 7-day treatment with metronidazole + miconazole (Neo-Penotran)VA triple-active pessary for the treatment of single and mixed vaginal infections. Int J Gynaecol Obstet 2001; 74:35-43.
9. Kukner S, Ergin T, Cicek N, et al. Treatment of vaginitis. Int J Gynaecol Obstet 1996; 52:43-47.
10. Muzny CA, Rivers CA, Mena LA, et al. Genotypic characterization of Trichomonas vaginalis isolates among women who have sex with women in sexual partnerships. Sex Transm Dis 2012;39:556-558.
11. Sutton M, Sternberg M, Koumans EH, et al. The prevalence of Trichomonas vaginalis infection among reporoductive-age women in the United States, 2001-2004. Clin Inf Dis 2007; 45:1319-1326.
12. Bachmann L, Lewis I, Allen R, et al. Risk and prevalence of treatable sexually transmitted diseases at a Birmingham substance abuse treatment facility. Am J Public Health 2000; 90:1615-1618.
13. Schwebke J, Venglarik M, Morgan S. Delayed versus immediate bedside inoculation of culture media for diagnosis of vaginal trichomonosis. J Clin Microbiol 1999; 37:2369-2370.
14. Sorvillo F, Kerndt P. Trichomonas vaginalis and amplification of HIV-1 transmission. Lancet 1998; 351:213-214.
15. Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: Results from a cohort study. AIDS 1993;7:95-102.
16. Klouman E, Massenga EJ, Klepp KI, et al. HIV and reproductive tract infections in a total village population in rural Kilimanjaro, Tanzania: Women at increased risk. J AIDS Human Retroviral 1997; 14:163-168.
17. Leroy V, De Clercq A, Ladner J, et al. Should screening of genital infections be part of antenatal care in areas of high HIV prevalencé A prospective cohort study from Kigali, Rwanda, 1992-1993. Genitourin Med 1995; 71:207-211.
18. Salvatore M, Meyers B. Metronidazole. In: Mandell G, Bennett J, Dolin R, eds. Principles and Practices of Infectious Diseases. Philadelphia, PA: Curchill Livingstone/Elsevier, 2010:419-426.
19. Schwebke J, Desmond RA. Tinidazole versus metronidazole for the treatment of bacterial vaginosis. Am J Obstet Gynecol 2011; 204:211.e1-6.
20. Schwebke JR, Barrientes FJ. Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole. Antimicrob Agents Chemother 2006; 50:4209-4210.
21. Kirkcaldy R, Augostini P, Asbel L, et al. Trichomonas vaginalis antimicrobial drug resistance in 6 US cities, STD Surveillance Network, 2009-2010. Emerg Infect Dis 2012; 18:939-943.
22. Muzny C, Barnes A, Mena L. Symptomatic Trichomonas vaginalis infection in the seting of severe nitroimidazole allergy: Successful treatment with boric acid. Sex Health 2012; 9:389-391.
23. Nyirjesy P, Sobel JD, Weitz MV, et al. Difficult-to treat trichomoniasis: Results with paromomycin cream. Clin Infect Dis 1998; 26:986-988.